Anthony Gibney Sells Shares of AURA $AURA
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Anthony Gibney, Chief Financial and Business Officer. at Aura Biosciences, Inc. ($AURA), sold 12,824 shares at an average price of $6.42, for a total transaction of $82,330.08. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Aura Biosciences, Inc. Stock Down 12.8%
Shares of Aura Biosciences, Inc. ($AURA) traded around $6.45 on Tuesday, down 12.8% for the day.
Aura Biosciences, Inc. Earnings
Analysts Set New Price Targets
About Aura Biosciences, Inc.
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Get Aura Biosciences, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AURA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.